'WHO Warns On Deadlier Strain Of Mpox' - Axios
Portfolio Pulse from Benzinga Newsdesk
The World Health Organization (WHO) is considering declaring an international public health emergency due to a deadlier strain of mpox spreading in Africa. The virus has a 3% mortality rate and has seen a 160% increase in cases this year. Vaccines and public health surveillance are crucial for controlling the outbreak.
August 05, 2024 | 4:09 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
GeoVax Labs, involved in vaccine development, could benefit from increased attention and funding for mpox vaccines as WHO considers declaring an international public health emergency.
GeoVax Labs' involvement in vaccine development positions it to benefit from increased funding and attention if WHO declares an emergency.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Inovio Pharmaceuticals, which focuses on DNA-based vaccines, may see increased interest in its technology as WHO considers declaring an international public health emergency for a deadlier strain of mpox.
Inovio Pharmaceuticals' focus on DNA-based vaccines could attract more interest if WHO declares an emergency, leading to potential demand for its technology.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Moderna, known for its mRNA technology, could see increased demand for its vaccine development capabilities as WHO considers declaring an international public health emergency for a deadlier strain of mpox.
Moderna's expertise in mRNA technology positions it well to respond to increased demand for vaccines if WHO declares an emergency.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
SIGA Technologies, which produces antiviral treatments, could see a surge in demand for its products as WHO considers declaring an international public health emergency for a deadlier strain of mpox.
SIGA Technologies' antiviral treatments could become more critical if WHO declares an emergency, leading to increased demand.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80